Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of ERBB2 rather than EGFR-Reference-Cited by-同舟云学术

Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation of ERBB2 rather than EGFR

Published:2005-11-15 Issue:22 Volume:11 Page:8105-8108
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Cohen Ezra E.W.,Lingen Mark W.,Martin Leslie E.,Harris Patricia L.,Brannigan Brian W.,Haserlat Sara M.,Okimoto Ross A.,Sgroi Dennis C.,Dahiya Sonika,Muir Beth,Clark John R.,Rocco James W.,Vokes Everett E.,Haber Daniel A.,Bell Daphne W.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer;Pharmaceutics;2024-09-11

2. Protein–protein-interaction assay coupled with proteome profiler and immune activation flow cytometry assay validate immune activation in 3D oral cancer-immune co-culture model;Journal of Proteins and Proteomics;2024-06-16

3. Human Papilloma Virus Positive Oropharyngeal Squamous Cell Carcinoma and the Immune System: Pathogenesis, Immunotherapy and Future Perspectives;International Journal of Molecular Sciences;2024-02-28

4. Anti-tumor Efficacy and Potential Mechanism of Pyrotinib in Locally Advanced Oral Squamous Cell Carcinoma;2023-10-17

5. Predictive Value of EGFR-PI3K-AKT-mTOR-Pathway Inhibitor Biomarkers for Head and Neck Squamous Cell Carcinoma: A Systematic Review;Molecular Diagnosis & Therapy;2021-03